NCT00263354View on ClinicalTrials.gov

Oxaliplatin in Gastric Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

July 31, 2006

Study Completion Date

July 31, 2006

Conditions
Stomach Neoplasms
Interventions
DRUG

Oxaliplatin

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00263354 - Oxaliplatin in Gastric Cancer | Biotech Hunter | Biotech Hunter